Table 2.

Univariate analysis of clinical factors associated with survival time since hospice ward admission

	Correlation coefficient	P value
Sex	-0.115	0.148
Age	0.001	0.987
Age > = 65 years old	0.069	0.386
Charlson comorbidity index	0.023	0.774
Palliative prognostic index	-0.305**	< 0.001
Palliative prognostic score	-0.352**	< 0.001
Hospice ward hospitalization days	0.710**	< 0.001
Cancer Sites
Hepatobiliary cancer	-0.174*	0.028
Urogenital system cancer	-0.059	0.461
Breast cancer	-0.069	0.384
Colorectal cancer	-0.024	0.762
Lung cancer	-0.054	0.500
Esophageal and Gastric cancer	0.110	0.164
Head and Neck cancer	0.273*	< 0.001
Others	0.035	0.663
Cancer Metastases sites
Brain metastases	0.058	0.465
Lymph node metastases	-0.027	0.738
Lung metastases	-0.020	0.799
Liver metastases	-0.228**	0.004
Bone metastases	-0.018	0.824
Activity daily living < 20 when admission	0.068	0.392
Laboratory data
Neutrophil percentage	-0.109	0.169
Lymphocyte percentage	0.078	0.329
Neutrophil to lymphocyte ratio	-0.170*	0.032
Nasogastric tube use	0.069	0.385
Feeding gastrostomy or jejunostomy	0.400**	< 0.001
Tracheostomy	0.342**	< 0.001
Foley catheter use	-0.057	0.476
Treatments when starting hospice ward admission
Parenteral nutrition use	0.000	1
Antibiotic use	-0.169*	0.033
Oxygen use	-0.070	0.377
Treatments during hospice ward hospitalization
Subcutaneous morphine use	-0.119	0.135
Total sedation	0.221**	0.005
Blood transfusion	0.327**	< 0.001
Parenteral nutrition	0.048	0.549

^*p value < 0.05, ** p value < 0.01